← Leaderboards
Christopher Lee Holley
Duke University
$5,101,144
Attributed
$6,269,254
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,269,254 · 5
By mechanism
R01$5,496,036 · 3
K08$614,218 · 1
R03$159,000 · 1
Top collaborators
- Neil J. Freedman4 shared
Most similar at Duke University
Same institution · by research overlap
- Neil J. Freedman$13,528,793
- Sudha K Shenoy$7,623,703
- Stacy Michelle Horner$8,997,349
- Michael D Gunn$25,515,208
- Karsten Peppel$4,062,655
Others in their field
Top investigators on “Small Nucleolar Rna”
- John Joseph Rossi · City Of Hope National Medical Center$12,406,272
- Chuan He · University Of Chicago$10,073,662
- Susan J Baserga · Yale University$8,053,703
- Juli F Feigon · University Of Calif-Los Alamos Nat Lab$6,743,839
- Janine M Lasalle · University Of California At Davis$5,744,473
- Arlen W Johnson · University Of Texas Austin$5,565,214
Research focus
Small Nucleolar RnaReactive Oxygen SpeciesIn VivoOxidative StressProteinsLinkIn VitroMessenger RnaMediatingEnzymesGeneticSiteTranslationsTranscriptomeFibrillarinAffectRecruitRibosomal RnaMethylationProtein ExpressionOverexpressionGuide RnaCellsKnock-Down
Grant awards (21)
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis$586,990
R01 · FY2025 · HL
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis$575,250
R01 · FY2024 · HL
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis$586,990
R01 · FY2023 · HL
The Role of RNA Modifications in Heart Failure$362,250
R01 · FY2023 · HL · contact PI
SnoRNA-guided modifications of mRNA$322,000
R01 · FY2023 · GM · contact PI
Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis$586,990
R01 · FY2022 · HL
The Role of RNA Modifications in Heart Failure$362,250
R01 · FY2022 · HL · contact PI
SnoRNA-guided modifications of mRNA$322,000
R01 · FY2022 · GM · contact PI
The Role of RNA Modifications in Heart Failure$362,250
R01 · FY2021 · HL · contact PI
SnoRNA-guided modifications of mRNA$322,000
R01 · FY2021 · GM · contact PI
The Role of RNA Modifications in Heart Failure$362,250
R01 · FY2020 · HL · contact PI
SnoRNA-guided modifications of mRNA$322,000
R01 · FY2020 · GM · contact PI
SnoRNA-guided modifications of mRNA$61,128
R01 · FY2020 · GM · contact PI
The Role of RNA Modifications in Heart Failure$361,688
R01 · FY2019 · HL · contact PI
Role of snoRNAs in regulation of cardiac hypertrophy$79,500
R03 · FY2017 · HL · contact PI
SNORNAS ARE ESSENTIAL MEDIATORS OF ROS SIGNALING IN CARDIOVASCULAR CELLS$161,374
K08 · FY2016 · HL · contact PI
Role of snoRNAs in regulation of cardiac hypertrophy$79,500
R03 · FY2016 · HL · contact PI
SNORNAS ARE ESSENTIAL MEDIATORS OF ROS SIGNALING IN CARDIOVASCULAR CELLS$113,211
K08 · FY2015 · HL · contact PI
SNORNAS ARE ESSENTIAL MEDIATORS OF ROS SIGNALING IN CARDIOVASCULAR CELLS$113,211
K08 · FY2014 · HL · contact PI
SNORNAS ARE ESSENTIAL MEDIATORS OF ROS SIGNALING IN CARDIOVASCULAR CELLS$113,211
K08 · FY2013 · HL · contact PI
SNORNAS ARE ESSENTIAL MEDIATORS OF ROS SIGNALING IN CARDIOVASCULAR CELLS$113,211
K08 · FY2012 · HL · contact PI